EnWave Successfully Commercializes nutraREV(TM) Food Dehydration ...(Dr. Tim Durance Chairman and Co-CEO of E...)

Date:3/2/2009

Dr. Tim Durance, Chairman and Co-CEO of EnWave, stated that "it has been more than 10 years since I began experimenting with nutraREV(TM) technology in my laboratory at the University of British Columbia. I strongly believe that we have developed a competitive new method for food dehydration which offers consumers rich textures, concentrated flavours and excellent nutritional and environmental benefits. We will continue to work with CAL-SAN to provide on-going support of their operation and to assist in the development of new product initiatives."

About CAL-SAN Enterprises

CAL-SAN Enterprises Ltd. is a blueberry and cranberry farming and processing operation, privately owned by the Sandhu family, and headquartered in Richmond, B.C. The 15 year old company has over 200 acres in production, along with a new 30,000 square foot facility capable of processing up to 7 million pounds of fruit annually. In 2007, the Company's new fruit winery, SANDUZ Estate Wines, was selected as the Best New Business of the Year by the Richmond Chamber of Commerce.

About EnWave

Using proprietary technologies developed in conjunction with the University of British Columbia, EnWave is focused on the development of new methods of dehydrating biological and food materials using Radiant Energy Vacuum technology under its bioREV(TM), freezeREV, nutraREV(TM) and powderREV brands. REV technology combines microwave energy transfer with pressure control to dehydrate and alter structures and drive chemical reactions, thereby creating unique product characteristics for both food products and medical applications that include dry vaccines and antibodies. More information about EnWave is available at www.enwave.net.

    EnWave Corporation
    Mr. John McNicol
    President & Co-CEO

This press release may contain forwar
'/>"/>

SOURCE EnWave Corporation Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme
2. Life on Mars pregnancy test successfully launched
3. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
4. Phase I Safety and Tolerability Study With EVT 302 Successfully Completed
5. SBT Acquisition Inc. Successfully Completes Tender Offer for Shares of Lifecore Biomedical, Inc.
6. Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period
7. TopoTarget Successfully Buys Back Full Control of Belinostat
8. Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
9. Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration
10. CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement : Australia/New Zealand Regulatory-Cleared Evaluation Registry is Expected to Lead to Market Clearance for These Countries
11. SAFC Hitech(TM) Successfully Demonstrates Device-Quality GST Precursors For Phase Change Memory Applications